{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:02:06Z","timestamp":1775696526761,"version":"3.50.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.rdc.2007.12.006","type":"journal-article","created":{"date-parts":[[2008,3,12]],"date-time":"2008-03-12T14:37:26Z","timestamp":1205332646000},"page":"73-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Vascular Disease in Scleroderma: Angiogenesis and Vascular Repair"],"prefix":"10.1016","volume":"34","author":[{"given":"Mary Jo","family":"Mulligan-Kehoe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Simons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.rdc.2007.12.006_bib1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.jidsymp.5650016","article-title":"Molecular mechanisms of VEGF-A action during tissue repair","volume":"11","author":"Eming","year":"2006","journal-title":"J Investig Dermatol Symp Proc"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib2","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.humpath.2005.10.007","article-title":"The differential expression of VEGF, VEGFR-2, and GLUT-1 proteins in disease subtypes of systemic sclerosis","volume":"37","author":"Davies","year":"2006","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/art.1780370218","article-title":"Immunocytochemical localization and serologic detection of transforming growth factor beta 1: association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon","volume":"37","author":"Higley","year":"1994","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.rdc.2007.12.006_bib4","first-page":"641","article-title":"Increased but imbalanced expression of VEGF and its receptors has no positive effect on angiogenesis in systemic sclerosis skin","volume":"20","author":"Mackiewicz","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11926-007-0013-2","article-title":"Current concepts in normal and defective angiogenesis: implications for systemic sclerosis","volume":"9","author":"Mulligan-Kehoe","year":"2007","journal-title":"Curr Rheumatol Rep"},{"issue":"20","key":"10.1016\/j.rdc.2007.12.006_bib6","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.1200\/JCO.2007.12.1509","article-title":"Experience with bevacizumab in the management of epithelial ovarian cancer","volume":"25","author":"Burger","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"31","key":"10.1016\/j.rdc.2007.12.006_bib7","doi-asserted-by":"crossref","first-page":"8033","DOI":"10.1200\/JCO.2005.01.9661","article-title":"Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer","volume":"23","author":"Kindler","year":"2005","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1161\/01.RES.88.2.167","article-title":"Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells","volume":"88","author":"Gill","year":"2001","journal-title":"Circ Res"},{"issue":"9434","key":"10.1016\/j.rdc.2007.12.006_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0140-6736(04)16853-0","article-title":"Defective vasculogenesis in systemic sclerosis","volume":"364","author":"Kuwana","year":"2004","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.rdc.2007.12.006_bib10","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1002\/art.22035","article-title":"Bone marrow endothelial progenitors are defective in systemic sclerosis","volume":"54","author":"Del Papa","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2007.12.006_bib11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1002\/art.22698","article-title":"Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis","volume":"56","author":"Cipriani","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2007.12.006_bib12","first-page":"457","article-title":"Nailfold video-capillaroscopy in systemic sclerosis","volume":"63","author":"Cutolo","year":"2004","journal-title":"Z\u00a0Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2007.12.006_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/01.RES.0000134644.89917.96","article-title":"Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis","volume":"95","author":"Distler","year":"2004","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.rdc.2007.12.006_bib14","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1161\/01.CIR.0000159345.00591.8F","article-title":"Angiogenesis: where do we stand now?","volume":"111","author":"Simons","year":"2005","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.rdc.2007.12.006_bib15","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nrd1226","article-title":"Therapeutic angiogenesis in cardiovascular disease","volume":"2","author":"Simons","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"10.1016\/j.rdc.2007.12.006_bib16","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1006\/bbrc.1999.0612","article-title":"Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells","volume":"258","author":"Lu","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib17","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1582-4934.2005.tb00356.x","article-title":"Angiogenesis inhibitors found within the haemostasis pathway","volume":"9","author":"Staton","year":"2005","journal-title":"J Cell Mol Med"},{"issue":"4","key":"10.1016\/j.rdc.2007.12.006_bib18","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0889-857X(05)70300-8","article-title":"Raynaud's phenomenon","volume":"22","author":"Wigley","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.rdc.2007.12.006_bib19","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1002\/art.21383","article-title":"The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis","volume":"52","author":"Giusti","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.rdc.2007.12.006_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00058-4","article-title":"Bioregulation of kinins: kallikreins, kininogens, and kininases","volume":"44","author":"Bhoola","year":"1992","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.rdc.2007.12.006_bib21","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/j.1538-7836.2007.02770.x","article-title":"The plasma kallikrein\/kinin systems: its evolution from contact activation","volume":"5","author":"Schmaier","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.rdc.2007.12.006_bib22","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1515\/BC.2000.135","article-title":"Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells","volume":"381","author":"Plendl","year":"2000","journal-title":"Biol Chem"},{"issue":"9","key":"10.1016\/j.rdc.2007.12.006_bib23","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0165-6147(00)01761-2","article-title":"Targeting kinin receptors for the treatment of tissue ischaemia","volume":"22","author":"Emanueli","year":"2001","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.rdc.2007.12.006_bib24","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/ard.2004.023382","article-title":"Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement","volume":"64","author":"Del Rosso","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.rdc.2007.12.006_bib25","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar2002","article-title":"A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients","volume":"8","author":"Giusti","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.rdc.2007.12.006_bib26","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/hq0701.093685","article-title":"Role of the matrix metalloproteinase and plasminogen activator\u2013plasmin systems in angiogenesis","volume":"21","author":"Pepper","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"46","key":"10.1016\/j.rdc.2007.12.006_bib27","doi-asserted-by":"crossref","first-page":"29461","DOI":"10.1074\/jbc.271.46.29461","article-title":"Kringle domains of human angiostatin: characterization of the anti-proliferative activity on endothelial cells","volume":"271","author":"Cao","year":"1996","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.rdc.2007.12.006_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/abbi.1997.0145","article-title":"Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF","volume":"344","author":"Keck","year":"1997","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"10.1016\/j.rdc.2007.12.006_bib29","first-page":"325","article-title":"The role of TGF-beta signaling in the pathogenesis of fibrosis in scleroderma","volume":"50","author":"Ihn","year":"2002","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.0022-202X.2004.23601.x","article-title":"Effects of hepatocyte growth factor on the expression of type I collagen and matrix metalloproteinase-1 in normal and scleroderma dermal fibroblasts","volume":"124","author":"Jinnin","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"14","key":"10.1016\/j.rdc.2007.12.006_bib31","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1021\/bi9731798","article-title":"Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3)","volume":"37","author":"Lijnen","year":"1998","journal-title":"Biochemistry"},{"issue":"41","key":"10.1016\/j.rdc.2007.12.006_bib32","doi-asserted-by":"crossref","first-page":"29568","DOI":"10.1074\/jbc.274.41.29568","article-title":"Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance","volume":"274","author":"O'Reilly","year":"1999","journal-title":"J Biol Chem"},{"issue":"46","key":"10.1016\/j.rdc.2007.12.006_bib33","doi-asserted-by":"crossref","first-page":"28823","DOI":"10.1074\/jbc.272.46.28823","article-title":"Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B\/type IV collagenase (MMP-9)","volume":"272","author":"Patterson","year":"1997","journal-title":"J Biol Chem"},{"issue":"33","key":"10.1016\/j.rdc.2007.12.006_bib34","doi-asserted-by":"crossref","first-page":"20641","DOI":"10.1074\/jbc.272.33.20641","article-title":"Generation of angiostatin by reduction and proteolysis of plasmin: catalysis by a plasmin reductase secreted by cultured cells","volume":"272","author":"Stathakis","year":"1997","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.rdc.2007.12.006_bib35","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/art.22861","article-title":"Antiangiogenic plasma activity in patients with systemic sclerosis","volume":"56","author":"Mulligan-Kehoe","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.rdc.2007.12.006_bib36","first-page":"H1432","article-title":"Effects of D-4F on vasodilation, oxidative stress, angiostatin, myocardial inflammation, and angiogenic potential in tight-skin mice","volume":"293","author":"Weihrauch","year":"2007","journal-title":"Am J Physiol"},{"issue":"5","key":"10.1016\/j.rdc.2007.12.006_bib37","first-page":"508","article-title":"Decreased ratio of circulatory vascular endothelial growth factor to endostatin in patients with systemic sclerosis: association with pulmonary involvement","volume":"24","author":"Dziankowska-Bartkowiak","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2007.12.006_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1083\/jcb.100.1.86","article-title":"A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase","volume":"100","author":"Vassalli","year":"1985","journal-title":"J Cell Biol"},{"issue":"51","key":"10.1016\/j.rdc.2007.12.006_bib39","doi-asserted-by":"crossref","first-page":"32380","DOI":"10.1016\/S0021-9258(18)31646-6","article-title":"Identification of the urokinase receptor as an adhesion receptor for vitronectin","volume":"269","author":"Wei","year":"1994","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.rdc.2007.12.006_bib40","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1002\/art.20562","article-title":"Matrix metalloproteinase 12-dependent cleavage of urokinase receptor in systemic sclerosis microvascular endothelial cells results in impaired angiogenesis","volume":"50","author":"D'Alessio","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.rdc.2007.12.006_bib41","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1002\/art.22263","volume":"54","author":"Margheri","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5435","key":"10.1016\/j.rdc.2007.12.006_bib42","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1126\/science.285.5435.1926","article-title":"Antiangiogenic activity of the cleaved conformation of the serpin antithrombin","volume":"285","author":"O'Reilly","year":"1999","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib43","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1182\/blood-2003-07-2192","article-title":"Alphastatin, a 24-amino acid fragment of human fibrinogen, is a potent new inhibitor of activated endothelial cells in vitro and in vivo","volume":"103","author":"Staton","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.rdc.2007.12.006_bib44","first-page":"2520","article-title":"Anti-angiogenic cues from vascular basement membrane collagen","volume":"60","author":"Colorado","year":"2000","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib45","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1074\/jbc.275.2.1209","article-title":"Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth","volume":"275","author":"Kamphaus","year":"2000","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.rdc.2007.12.006_bib46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1245\/s10434-006-9009-9","article-title":"An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I","volume":"13","author":"Beecken","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib47","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","article-title":"Endostatin: an endogenous inhibitor of angiogenesis and tumor growth","volume":"88","author":"O'Reilly","year":"1997","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib48","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1210\/endo-129-2-896","article-title":"The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells","volume":"129","author":"Ferrara","year":"1991","journal-title":"Endocrinology"},{"issue":"11","key":"10.1016\/j.rdc.2007.12.006_bib49","doi-asserted-by":"crossref","first-page":"8588","DOI":"10.1074\/jbc.M006434200","article-title":"A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product","volume":"276","author":"Mulligan-Kehoe","year":"2001","journal-title":"J Biol Chem"},{"issue":"31","key":"10.1016\/j.rdc.2007.12.006_bib50","doi-asserted-by":"crossref","first-page":"29000","DOI":"10.1074\/jbc.M301042200","article-title":"Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a)","volume":"278","author":"Kim","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.rdc.2007.12.006_bib51","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1083\/jcb.122.2.497","article-title":"Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity","volume":"122","author":"Tolsma","year":"1993","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/j.rdc.2007.12.006_bib52","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2005.01.007","article-title":"TIMP-2: an endogenous inhibitor of angiogenesis","volume":"11","author":"Stetler-Stevenson","year":"2005","journal-title":"Trends Mol Med"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X07001056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X07001056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:07:19Z","timestamp":1760180839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X07001056"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0889857X07001056"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2007.12.006","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vascular Disease in Scleroderma: Angiogenesis and Vascular Repair","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2007.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}